Tandem Diabetes Care Issues Recall for Mobi Insulin Pumps Over False Alarms

Tandem Diabetes Care has initiated a correction for over 80,000 Mobi insulin pumps due to false occlusion alarms, which can disrupt insulin delivery and potentially cause high blood glucose levels. The company has received 230 reports of adverse events, some requiring medical intervention or hospitalization. This recall addresses a significant patient safety concern, highlighting the importance of reliable medical device function.